These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1084 related articles for article (PubMed ID: 33597531)

  • 41. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO.
    Wu J; Shi Y; Pan X; Wu S; Hou R; Zhang Y; Zhong T; Tang H; Du W; Wang L; Wo J; Mu J; Qiu Y; Yang K; Zhang LK; Ye BC; Qi N
    Cell Rep; 2021 Feb; 34(7):108761. PubMed ID: 33567255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-Term Existence of SARS-CoV-2 in COVID-19 Patients: Host Immunity, Viral Virulence, and Transmissibility.
    Wang X; Huang K; Jiang H; Hua L; Yu W; Ding D; Wang K; Li X; Zou Z; Jin M; Xu S
    Virol Sin; 2020 Dec; 35(6):793-802. PubMed ID: 33156486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019.
    Ramos da Silva S; Ju E; Meng W; Paniz Mondolfi AE; Dacic S; Green A; Bryce C; Grimes Z; Fowkes M; Sordillo EM; Cordon-Cardo C; Guo H; Gao SJ
    J Infect Dis; 2021 Jun; 223(11):1842-1854. PubMed ID: 33837392
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Local and systemic responses to SARS-CoV-2 infection in children and adults.
    Yoshida M; Worlock KB; Huang N; Lindeboom RGH; Butler CR; Kumasaka N; Dominguez Conde C; Mamanova L; Bolt L; Richardson L; Polanski K; Madissoon E; Barnes JL; Allen-Hyttinen J; Kilich E; Jones BC; de Wilton A; Wilbrey-Clark A; Sungnak W; Pett JP; Weller J; Prigmore E; Yung H; Mehta P; Saleh A; Saigal A; Chu V; Cohen JM; Cane C; Iordanidou A; Shibuya S; Reuschl AK; Herczeg IT; Argento AC; Wunderink RG; Smith SB; Poor TA; Gao CA; Dematte JE; ; Reynolds G; Haniffa M; Bowyer GS; Coates M; Clatworthy MR; Calero-Nieto FJ; Göttgens B; O'Callaghan C; Sebire NJ; Jolly C; De Coppi P; Smith CM; Misharin AV; Janes SM; Teichmann SA; Nikolić MZ; Meyer KB
    Nature; 2022 Feb; 602(7896):321-327. PubMed ID: 34937051
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T Cells: Warriors of SARS-CoV-2 Infection.
    de Candia P; Prattichizzo F; Garavelli S; Matarese G
    Trends Immunol; 2021 Jan; 42(1):18-30. PubMed ID: 33277181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection.
    Pérez-Gómez A; Vitallé J; Gasca-Capote C; Gutierrez-Valencia A; Trujillo-Rodriguez M; Serna-Gallego A; Muñoz-Muela E; Jiménez-Leon MLR; Rafii-El-Idrissi Benhnia M; Rivas-Jeremias I; Sotomayor C; Roca-Oporto C; Espinosa N; Infante-Domínguez C; Crespo-Rivas JC; Fernández-Villar A; Pérez-González A; López-Cortés LF; Poveda E; Ruiz-Mateos E;
    Cell Mol Immunol; 2021 Sep; 18(9):2128-2139. PubMed ID: 34290398
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Switched and unswitched memory B cells detected during SARS-CoV-2 convalescence correlate with limited symptom duration.
    Newell KL; Clemmer DC; Cox JB; Kayode YI; Zoccoli-Rodriguez V; Taylor HE; Endy TP; Wilmore JR; Winslow GM
    PLoS One; 2021; 16(1):e0244855. PubMed ID: 33507994
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood neutrophils from children with COVID-19 exhibit both inflammatory and anti-inflammatory markers.
    Seery V; Raiden SC; Algieri SC; Grisolía NA; Filippo D; De Carli N; Di Lalla S; Cairoli H; Chiolo MJ; Meregalli CN; Gimenez LI; Gregorio G; Sarli M; Alcalde AL; Davenport C; Bruera MJ; Simaz N; Pérez MF; Nivela V; Bayle C; Tuccillo P; Agosta MT; Pérez H; Villa Nova S; Suárez P; Takata EM; García M; Lattner J; Rolón MJ; Coll P; Sananez I; Holgado MP; Ferrero F; Geffner J; Arruvito L;
    EBioMedicine; 2021 May; 67():103357. PubMed ID: 33979758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients.
    Flehmig B; Schindler M; Ruetalo N; Businger R; Bayer M; Haage A; Kirchner T; Klingel K; Normann A; Pridzun L; Tougianidou D; Ranke MB
    Viruses; 2020 Nov; 12(12):. PubMed ID: 33260809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Summary for Patients: What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 1).
    Ann Intern Med; 2021 Jun; 174(6):I26. PubMed ID: 33721515
    [No Abstract]   [Full Text] [Related]  

  • 51. Sex-Related Differences in Innate and Adaptive Immune Responses to SARS-CoV-2.
    Agrawal S; Salazar J; Tran TM; Agrawal A
    Front Immunol; 2021; 12():739757. PubMed ID: 34745109
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
    Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y
    Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune profiling of COVID-19: preliminary findings and implications for the pandemic.
    Maecker HT
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33963016
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interrogation of the cellular immunome of cancer patients with regard to the COVID-19 pandemic.
    Donahue RN; Marté JL; Goswami M; Toney NJ; Tsai YT; Gulley JL; Schlom J
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33707314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biomarkers and Immune Repertoire Metrics Identified by Peripheral Blood Transcriptomic Sequencing Reveal the Pathogenesis of COVID-19.
    Liu Y; Wu Y; Liu B; Zhang Y; San D; Chen Y; Zhou Y; Yu L; Zeng H; Zhou Y; Zhou F; Yang H; Yin L; Huang Y
    Front Immunol; 2021; 12():677025. PubMed ID: 34504487
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dysregulated Immune Responses in COVID-19 Patients Correlating With Disease Severity and Invasive Oxygen Requirements.
    García-González P; Tempio F; Fuentes C; Merino C; Vargas L; Simon V; Ramirez-Pereira M; Rojas V; Tobar E; Landskron G; Araya JP; Navarrete M; Bastias C; Tordecilla R; Varas MA; Maturana P; Marcoleta AE; Allende ML; Naves R; Hermoso MA; Salazar-Onfray F; Lopez M; Bono MR; Osorio F
    Front Immunol; 2021; 12():769059. PubMed ID: 34745145
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Dynamic Immunological Parameter Landscape in Coronavirus Disease 2019 Patients With Different Outcomes.
    Tang G; Huang M; Luo Y; Liu W; Lin Q; Mao L; Wu S; Xiong Z; Hou H; Sun Z; Wang F
    Front Immunol; 2021; 12():697622. PubMed ID: 34777333
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In Nasal Mucosal Secretions, Distinct IFN and IgA Responses Are Found in Severe and Mild SARS-CoV-2 Infection.
    Dos Santos JMB; Soares CP; Monteiro FR; Mello R; do Amaral JB; Aguiar AS; Soledade MP; Sucupira C; De Paulis M; Andrade JB; Almeida FJ; Sáfadi MAP; Mau LB; Brasil JM; Ramalho T; Loures FV; Vieira RP; Durigon EL; de Oliveira DBL; Bachi ALL
    Front Immunol; 2021; 12():595343. PubMed ID: 33717074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome.
    Borges RC; Hohmann MS; Borghi SM
    Int Rev Immunol; 2021; 40(1-2):108-125. PubMed ID: 33191813
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SARS-CoV-2 innate effector associations and viral load in early nasopharyngeal infection.
    Liou TG; Adler FR; Cahill BC; Cox DR; Cox JE; Grant GJ; Hanson KE; Hartsell SC; Hatton ND; Helms MN; Jensen JL; Kartsonaki C; Li Y; Leung DT; Marvin JE; Middleton EA; Osburn-Staker SM; Packer KA; Shakir SM; Sturrock AB; Tardif KD; Warren KJ; Waddoups LJ; Weaver LJ; Zimmerman E; Paine R
    Physiol Rep; 2021 Feb; 9(4):e14761. PubMed ID: 33625796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.